Reactivation of fetal hemoglobin in patients with beta-thalassemia.
Olivieri
N F
NF
Hospital for Sick Children, Toronto, Ontario, Canada.
D001374:Azacitidine / Q000627:therapeutic use; D002087:Butyrates / Q000627:therapeutic use; D020148:Butyric Acid; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use; D005319:Fetal Hemoglobin / Q000096:biosynthesis*; D006720:Homozygote; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D016896:Treatment Outcome; D017086:beta-Thalassemia / Q000097:blood / Q000188:drug therapy* / Q000235:genetics
D002087:Butyrates; D020148:Butyric Acid; D004921:Erythropoietin; D005319:Fetal Hemoglobin; D001374:Azacitidine; D006918:Hydroxyurea